Nexalin Technology Inc. Common Stock (NXL)

About NXL

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 heads…

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Employees

8

Website

nexalin.com

Fundamentals

1-day range

$0.25$0.2596

Market cap

$8.03M

P/E (trailing)

—

P/E (forward)

-0.81

EPS (trailing)

$-0.46

Dividend yield

—

Beta

3.97

Avg. volume

241.7K

Forecasts

1 analyst ratings

Nexalin Technology Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NXL

  Nexalin Technology Inc. Common Stock

  $0.25

  ▲ 0.00%
  Market cap $8.03MP/E —
  $0.2201$2
• NDRA

  ENDRA Life Sciences Inc. Common Stock

  $5.16

  ▼ 4.63%
  Market cap $5.19MP/E —
  $2.96$9.85
• VBIO

  Valion Bio Inc. Common Stock

  $0.121

  ▼ 1.63%
  Market cap $1.31MP/E —
  $0.1116$1.3
• QTI

  QT Imaging Holdings Inc. Common Stock

  $3.09

  ▼ 0.96%
  Market cap $36.21MP/E —
  $2.62$19.05
• POCI

  Precision Optics Corporation Inc. Common stock

  $4.41

  ▼ 0.45%
  Market cap $45.86MP/E —
  $3.55$6.15
• STEX

  Streamex Corp. Common Stock

  $0.7649

  ▼ 7.51%
  Market cap $78.10MP/E —
  $0.6552$7.44
• NRXS

  Neuraxis Inc. Common Stock

  $5.98

  ▼ 0.66%
  Market cap $82.23MP/E —
  $2.21$9.33

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• These stocks are moving in today's session
  ChartMill · 8/27/2026
• Wondering what's happening in today's pre-market session?
  ChartMill · 8/27/2026

Institutional Ownership

March 31, 2026

Total shares held

1.00M

Total value held

$344.2K

Institutional holders

21